Syed Arsalan Ahmed Naqvi
@SyedArsalanN
Followers
366
Following
596
Media
19
Statuses
234
@MayoClinic || Alum, Dow Medical College || Biomedical Informatics & Living Evidence Syntheses
Joined August 2020
For those out there with less gray hair than me… Never underestimate the value in working with good people towards a common goal. You can always do more together Sometimes academia makes us forget that science is a team sport & no one does anything alone #ESMO25 @myESMO
This ongoing trial is part of an organic collaboration of investigators & @theNCI seeking knowledge re: #PSMA+ #BCR
@HelenMoonMD @laurasenamd @Dr_JeannyAC @EdwinPosadasMD @RPachynski @CathyHandy @CPDR_Labs @mbilusic @melissaabel20 @FatimaKarzai & others #ESMO25
1
7
19
Congratulations to this year's #WorldGU25 poster winners! We are excited to spotlight our 19 winners at the Poster Session & Welcome Reception at the 2-day CE-accredited conference in Nashville, TN, Aug 21-23. Join us and receive up to 11.75 CE credits. https://t.co/R9dYRQvvXE
0
10
22
Comparing ARPI options across disease volume and metastatic timing in #mHSPC. @SyedArsalanN and @IrbazRiaz @MayoClinic join @neerajaiims @huntsmancancer to discuss a 7,000-patient meta-analysis showing no major efficacy differences among abiraterone, apalutamide, enzalutamide &
0
6
18
Mayo Clinic’s Cancer Care Beyond Walls is transforming cancer treatment by bringing hospital-level care directly into the home, supporting quality of life and setting a new standard for more flexibility in care options for patients at scale:
mayomagazine.mayoclinic.org
Mayo Clinic takes cancer care beyond walls and into patients’ homes.
0
7
33
Thank you for communicating the data @PatrickHwuMD
Alan Bryce, MD (@AlanBryce9) of @cityofhope shares 5-year follow up from the Circulating Cell-free Genome Atlas (CCGA) study, a multi-cancer early detection test. Key takeaways: ➡️ A positive signal on a blood-based MCED test (CSD) is linked to worse survival, while a
1
3
11
@nsayeghmd @chadihcmd @ASCO @Huntsman_GU @umangtalking @ggebraelmd @montypal @PGrivasMDPhD @ziremozay @maughanonc @UtahIMCMRs @eddy_saad @JadChahoud @urotoday Congrats @chadihcmd for the fantastic oral presentation at the @ASCO #ASCO25 Proud of you. @Huntsman_GU @UUtah @UofUInternalMed Congrats to @umangtalking @YeonjungJoHCI
0
6
14
IMO the most important message here is the importance of paying attention to CV dz for men with advanced PC. Our must do checklist for men with advanced PC should include: 1) Germline + somatic NGS 2) Manage CV health 3) Manage Bone health
#ASCO25 @AlanBryce9 presented real-world data comparing CV risk in mCRPC pts treated with abiraterone (AA) vs enzalutamide (ENZA) 🇺🇸 📊 6,319 Medicare pts; PSM cohorts (n=2,913) ⚠️ AA associated with: • ↑ MACE-4 risk • ↑ AFib & VTE • ↑ all-cause mortality (HR ~1.14) 🫀
0
8
15
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer @ASCO Guideline Update https://t.co/n712hb1TWo The updated ASCO guideline provides evidence-based recommendations for the systemic treatment of patients with metastatic castration-resistant
0
33
73
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update now available: https://t.co/qXz2SMaaEj
0
1
3
Comparing ARPI options across disease volume and metastatic timing in #mHSPC. @SyedArsalanN and @IrbazRiaz @MayoClinic join @neerajaiims @huntsmancancer to discuss a 7,000-patient meta-analysis showing no major efficacy differences among abiraterone, apalutamide, enzalutamide &
0
8
13
From rotating here as a medical student to matching here for internal medicine residency, dreams do come true. Extremely grateful for the phenomenal mentorship by @IrbazRiaz. It was an incredible experience contributing to research in AI at @MayoClinic! Next Stop @CCF_IMCHIEFS
35
13
541
Thrilled to celebrate my incredible fellows matching into Internal Medicine Residency programs! 🎉 Your hard work, dedication, and resilience have been truly inspiring. It’s bittersweet seeing you move to the next chapter—you’ve become family. Super proud and excited to see all
22
16
105
Now, Dr. @Parminder1699 masterfully outlines the role of chemo-immunotherapy in urothelial carcinoma at @OncLive AZ highlighting the current state of evidence in an insightful and informative session w/ @IrbazRiaz @AlanBryce9 @ZakhariaYousef
0
5
10
Dr. @AlanBryce9 & @IrbazRiaz delivering an insightful talk at @OncLive, expertly breaking down the evolving treatment landscape of advanced #ProstateCancer with clarity and precision. If only we could all articulate it that eloquently! w/ @Parminder1699.
0
7
15
Bold. Forward. Unbound. in Arizona will physically and digitally transform healthcare to support Category-of-One healthcare for our patients. Read more: https://t.co/otRiqaKzDy
1
13
59
Excited to co-chair this first GU summit with @bilenma in Atlanta with great lineup of speakers @PBarataMD @CParkMD @RohanGarjeMD @maughanonc @binayshah @arnabguonc @virajmaster @DocMattCampbell @BasselNazha and many more can’t find on X, 15 travel grants offered to trainees.
📅 Join us at the Atlanta Genitourinary Cancers Summit on Mar. 15, co-chaired by Winship medical oncologist Mehmet Asim Bilen, MD, and Mayo Clinic's Yousef Zakharia, MD. Experts will discuss advancements in prostate, kidney, bladder cancers and more. ➡️ https://t.co/rpe4LAULYQ
3
19
61
🎉 Honored to be named a Gerstner Scholar in AI Translation at @MayoClinic! Excited to advance AI-driven innovations in oncology—leveraging large language models (LLMs) to enhance clinical trial outreach and patient communication, ensuring better access and engagement. Grateful
32
13
126
🚀 Proud moment for our BEACON | Riaz Lab team at #ASCOGU25! Our talented team are driving innovation in AI and health outcomes with impactful presentations. 🎤📊 Big thanks to our mentors for their support! @ZakhariaYousef @Parminder1699
#Oncology #AI #GU25 @MayoClinic
5
14
51
Choice of ARPi by disease volume and timing of metastases in metastatic hormone-sensitive #ProstateCancer. Presentation by Syed Naqvi, MD @MayoClinic. #GU25 written coverage by @RKSayyid @USC > https://t.co/ktIX0imjFE
0
4
7
It was a pleasure meeting you and presenting our poster, @jrgralow. I appreciate you taking the time to stop by and look forward to staying in touch! #ASCOGU25 @ASCO
Fun catching up with GU friends and colleagues at #GU25 @ASCO @DrChoueiri @JessicaHawleyMD @crisbergerot @NazliDizman @TiansterZhang @KainatWarraich6 @drulkav
1
3
15